AMPY vs EQNR

The company exhibits severe financial distress based on a Piotroski F-Score of 2/9, indicating weak financial health. Despite a low Price/Book of 0.49 and a forward P/E below sector average, persistent negative earnings surprises, declining revenue, and negative profit margin undermine valuation appeal. Operating margin and gross margin appear healthy but are inconsistent with overall profitability, which remains negative. The lack of Altman Z-Score and intrinsic value metrics, combined with deteriorating earnings trends and bearish technicals, suggests high risk.

Equinor exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is currently trading at a severe premium to its deterministic value. The current price of $37.94 is more than double the Graham Number ($18.78) and nearly triple the growth-based intrinsic value ($13.58). This valuation gap is compounded by sharply negative growth metrics, including a 27.3% YoY decline in earnings and a 0/100 bearish technical trend. While the balance sheet is healthier than the sector average, the combination of valuation overshoot and deteriorating fundamentals suggests significant downside risk.